> For the complete documentation index, see [llms.txt](https://assets-web3-or-or-ortusol-intern.gitbook.io/ortusol-international-oca-token-docs/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://assets-web3-or-or-ortusol-intern.gitbook.io/ortusol-international-oca-token-docs/why-section/markdown.md).

# Why cannabis?

The cannabis industry is one of the fastest growing global markets, driven by progressive legalization, increasing medical applications and evolving consumer acceptance. With a projected value of $73.6 billion by 2027 and a compound annual growth rate (CAGR) of 18.1%, the sector represents a strategic investment opportunity with high return potential.

**Market expansion and investment opportunities**

Cannabis is establishing itself as a key raw material in a variety of industries, from pharmaceuticals to food and wellness. As more countries regulate its production and trade, investors can access an expanding market with high demand and sustainable returns.

**Growth of medical cannabis in Europe**

Europe, Ortusol's primary target market, is experiencing rapid adoption of medical cannabis. The European market is estimated to reach $10.3 billion by 2027, driven by regulatory advances and an increase in the number of patients using therapeutic cannabis.

**Legalization and global expansion**

The growing acceptance of cannabis has led to unprecedented expansion in key markets:

* United States: 37 states have legalized medical cannabis and 21 allow its recreational use.
* Europe: countries such as Germany, Spain and the United Kingdom are moving forward with regulations for the production and distribution of medical cannabis.
* Latin America and Africa: emerging regions such as Uruguay, Colombia and Malawi are developing export-oriented production models.

**Cannabis diversification and applications**

Beyond recreational use, cannabis is being integrated into multiple high-growth sectors:

* Pharmaceuticals: development of drugs to treat epilepsy, chronic pain and neurological disorders.
* Food and beverages: incorporation of cannabinoids in supplements and functional products.
* Cosmetics and wellness: use of CBD in personal care products with anti-inflammatory and regenerative effects.